Encompass HealthEHC
紐約證券 · USD
101.67
+1.30
(+1.30%)
盤中 03/17 02:30 (UTC+8)
03/17 02:30 (UTC+8)
Encompass HealthEHC
101.67
+1.30
(+1.30%)
財務數據
損益表
- 12.07
- 12.47
- 13.16
- 13.01
- 13.51
- 14.05
- 14.55
- 14.58
- 14.78
- 15.45
- 1.67
- 3.31
- 5.55
- -1.12
- 3.83
- 4.00
- 3.59
- 0.16
- 1.36
- 4.54
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 1,544,600 | 1,477,500 | 1,457,700 | 1,455,400 | 1,405,000 | 1,351,000 | 1,301,200 | 1,316,000 | 1,246,800 | 1,206,900 |
營業成本 | 79,000 | 79,500 | 77,800 | 77,100 | 77,000 | 75,000 | 71,800 | 72,500 | 72,600 | 68,100 |
營業毛利 | 1,465,600 | 1,398,000 | 1,379,900 | 1,378,300 | 1,328,000 | 1,276,000 | 1,229,400 | 1,243,500 | 1,174,200 | 1,138,800 |
營業費用 | 1,182,200 | 1,154,400 | 1,120,800 | - | - | - | - | - | 984,300 | 959,400 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | 1,095,800 | 1,072,000 | 1,040,900 | 1,032,100 | 1,017,700 | 988,500 | 940,900 | 965,700 | 914,200 | 892,100 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 86,400 | 82,400 | 79,900 | 79,200 | 78,000 | 78,400 | 72,900 | 70,300 | 70,100 | 67,300 |
營業利益 | 283,400 | 243,600 | 259,100 | 267,000 | 232,300 | 209,100 | 215,600 | 207,500 | 189,900 | 179,400 |
其他收入及費用 | 3,700 | 5,900 | 6,700 | 2,500 | 1,900 | 8,900 | 3,300 | 5,400 | 8,900 | 500 |
利息費用 | 30,200 | 30,800 | 30,400 | 31,800 | 33,000 | 34,900 | 34,300 | 35,200 | 34,900 | 35,900 |
稅前純益 | 257,700 | 219,900 | 236,800 | 238,600 | 201,400 | 183,800 | 186,000 | 178,400 | 164,800 | 145,000 |
所得稅 | 55,400 | 44,900 | 51,000 | 41,600 | 37,600 | 36,000 | 38,300 | 38,300 | 37,200 | 30,300 |
稅後純益 | 146,100 | 126,500 | 142,100 | 151,500 | 120,900 | 108,200 | 114,100 | 112,500 | 87,600 | 85,300 |
基本每股稅後盈餘(元) | 1.45 | 1.26 | 1.41 | 1.50 | 1.20 | 1.08 | 1.13 | 1.12 | 0.87 | 0.85 |
稀釋每股稅後盈餘(元) | 1.43 | 1.24 | 1.39 | 1.48 | 1.18 | 1.06 | 1.12 | 1.10 | 0.85 | 0.85 |
基本平均股數(千股) | 100200.00 | 100500.00 | 100600.00 | 100500.00 | 100000.00 | 99900.00 | 99900.00 | 99800.00 | 99500.00 | 99500.00 |
稀釋平均股數(千股) | 102000.00 | 102300.00 | 102300.00 | 102100.00 | 102300.00 | 102100.00 | 102000.00 | 102200.00 | 101500.00 | 101400.00 |
還原基本每股稅後盈餘(元) | 1.45 | 1.26 | 1.41 | 1.50 | 1.20 | 1.08 | 1.13 | 1.12 | 0.87 | 0.85 |
還原稀釋每股稅後盈餘(元) | 1.43 | 1.24 | 1.39 | 1.48 | 1.18 | 1.06 | 1.12 | 1.10 | 0.85 | 0.85 |
還原基本平均股數(千股) | 100,200 | 100,500 | 100,600 | 100,500 | 100,000 | 99,900 | 99,900 | 99,800 | 99,500 | 99,500 |
還原稀釋平均股數(千股) | 102,000 | 102,300 | 102,300 | 102,100 | 102,300 | 102,100 | 102,000 | 102,200 | 101,500 | 101,400 |
EBITDA(千元) | 327,700 | 284,600 | 303,400 | 304,100 | 279,200 | 257,500 | 259,600 | 256,300 | 239,300 | 218,800 |